Application: We recommend the following antibodies for sandwich immunoassay (Capture - Detection): DMAB-CPT747 - DMAB-CPT748
Summary
Specifications
Antibody Isotype
IgG
Clone
351108C3
Species Reactivity
Human
Immunogen
MAEA fusion protein
Conjugate
Unconjugated
Applications
Application Notes
We recommend the following antibodies for sandwich immunoassay (Capture - Detection): DMAB-CPT747 - DMAB-CPT748 Cytometric Bead Array: 1.25-100 ng/mL
General Notes
This product (Catalog No. DMAB-CPT747) is a rabbit-derived monoclonal antibody raised against human MAEA. It has been affinity purified by Protein A. MAEA (macrophage erythroblast attacher) is a core component of the CTLH E3 ubiquitin-protein ligase complex. MAEA is required for normal cell proliferation and plays a role in erythroblast enucleation during erythrocyte maturation and in the development of mature macrophages. N-terminus MAEA and full-length MAEA are mostly expressed in nuclear and can be detected at low level in the cytoplasm of some cells, while C-terminus MAEA can be detected in the cytoplasm and nucleoli within the nucleus. MAEA mediates the attachment of erythroid cell to mature macrophages which can inhibit erythroid cell apoptosis. The expression of MAEA may be associated with the type 2 diabetes mellitus. DMAB-CPT747 is suitable for use in Cytometric Bead Array (1.25-100 ng/mL) application. DMAB-CPT747 is supplied as a liquid formulation in PBS only. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Magic™ Rabbit Anti-Human MAEA Monoclonal antibody, clone 351108C3
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.